Doublecortin-like kinase 1 is a therapeutic target in squamous cell carcinoma.
Standing D, Arnold L, Dandawate P, Ottemann B, Snyder V, Ponnurangam S, Sayed A, Subramaniam D, Srinivasan P, Choudhury S, New J, Kwatra D, Ramamoorthy P, Roy BC, Shadoin M, Al-Rajabi R, O'Neil M, Gunewardena S, Ashcraft J, Umar S, Weir SJ, Tawfik O, Padhye SB, Biersack B, Anant S, Thomas SM.
Standing D, et al. Among authors: umar s.
Mol Carcinog. 2023 Feb;62(2):145-159. doi: 10.1002/mc.23472. Epub 2022 Oct 11.
Mol Carcinog. 2023.
PMID: 36218231
Free PMC article.